Premium
No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure
Author(s) -
YUE Q.Y.,
BEERMANN B.,
LINDSTRÖM B.,
NYQUIST O.
Publication year - 1997
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.1997.tb00022.x
Subject(s) - medicine , heart failure , furosemide , thiamine , cardiology , thiamine deficiency
. Yue Q‐Y, Beermann B, Lindstrom B, Nyquist 0 (Huddinge University Hospital, Huddinge, and the Medical Product Agency, Uppsala, Sweden). No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. Intern Med 1997; 242:49 1‐49 5. Objectives: To determine whether furosemide treatment in congestive heart failure (CHF) patients is associated with thiamine deficiency. Design: Patients without heart failure and without diuretic treatment were included to compare with patients with CHF belonging to New York Heart Association (NYHA) functional class I1 and 111‐IV, respectively, and receiving furosemide therapy. Setting: All patients were recruited from the emergency ward of the cardiology section, Huddinge University Hospital, where they were admitted due to CHF or acute myocardial infarction. Subjects: Ninety‐nine patients were included from whom a blood sample was taken, as well as routine admission blood samples for the analysis of thiamine diphosphate (TPP) concentrations: Patients taking vitamin preparations were excluded. Main outcome measures: Blood TPP concentrations were measured by high performance liquid chromatography (HPLC) and compared between the patient groups by the use of ANOVA. Results: No significant difference was found between the groups in blood TPP concentrations. Conclusions: Thiamine deficiency may not be a complication of furosemide treatment in the studied Swedish patient population.